BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2404672)

  • 1. Genotyping of cutaneous T-cell lymphomas and pseudolymphomas.
    Bignon YJ; Souteyrand P
    Curr Probl Dermatol; 1990; 19():114-23. PubMed ID: 2404672
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene rearrangement studies in lymphoproliferative disorders of skin.
    Weiss LM; Wood GS; Nickoloff BJ; Sklar J
    Adv Dermatol; 1988; 3():141-60. PubMed ID: 3152817
    [No Abstract]   [Full Text] [Related]  

  • 3. Where are we today in the diagnosis of cutaneous lymphoma?
    Burg G; Kaudewitz P
    Curr Probl Dermatol; 1990; 19():90-104. PubMed ID: 2404686
    [No Abstract]   [Full Text] [Related]  

  • 4. CD30
    Ellis A; Christensen LF; Sharma T; Meyerson H; Kord H; Cooper KD
    J Am Acad Dermatol; 2021 Feb; 84(2):530-532. PubMed ID: 32437721
    [No Abstract]   [Full Text] [Related]  

  • 5. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.
    Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mycosis fungoides and Sézary syndrome, so-called cutaneous T-cell lymphoma].
    Rupniewska ZM
    Postepy Hig Med Dosw; 1982; 36(4):231-49. PubMed ID: 6764803
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis of malignant cutaneous lymphomas].
    Sterry W
    Dtsch Med Wochenschr; 1988 Feb; 113(5):184-9. PubMed ID: 3276493
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
    Edelson RL
    J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK
    G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manifestations of cutaneous T-cell lymphoma.
    Carney DN; Bunn PA
    J Dermatol Surg Oncol; 1980 May; 6(5):369-77. PubMed ID: 6966639
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytogenetics of T-cell malignant lymphoma. Report of 17 cases and review of the chromosomal breakpoints.
    Berger R; Baranger L; Bernheim A; Valensi F; Flandrin G
    Cancer Genet Cytogenet; 1988 Nov; 36(1):123-30. PubMed ID: 3060249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological differential diagnosis of mycosis fungoides/Sézary syndrome from the cutaneous type of adult T-cell leukemia/lymphoma].
    Johno M; Ono T
    Nihon Rinsho; 2000 Mar; 58(3):660-4. PubMed ID: 10741142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome.
    Whittaker SJ; Smith NP; Jones RR; Luzzatto L
    Cancer; 1991 Oct; 68(7):1572-82. PubMed ID: 1654197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMEM244 Gene Expression as a Potential Blood Diagnostic Marker Distinguishing Sézary Syndrome from Mycosis Fungoides and Benign Erythroderma.
    Rassek K; Iżykowska K; Żurawek M; Nowicka K; Joks M; Olek-Hrab K; Olszewska B; Sokołowska-Wojdyło M; Biernat W; Nowicki RJ; Przybylski GK
    J Invest Dermatol; 2023 Feb; 143(2):344-347.e3. PubMed ID: 36087622
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
    Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
    Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using molecular biologic analysis of T-cell receptor gene rearrangements to stage cutaneous T-cell lymphoma.
    Wood GS
    Arch Dermatol; 1998 Feb; 134(2):221-3. PubMed ID: 9487215
    [No Abstract]   [Full Text] [Related]  

  • 18. Clonal characteristics of cutaneous T cell lymphomas: cytogenetic evidence from blood, lymph nodes, and skin.
    Nowell PC; Finan JB; Vonderheid EC
    J Invest Dermatol; 1982 Jan; 78(1):69-75. PubMed ID: 6976392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biomarker landscape in mycosis fungoides and Sézary syndrome.
    Dulmage B; Geskin L; Guitart J; Akilov OE
    Exp Dermatol; 2017 Aug; 26(8):668-676. PubMed ID: 27897325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis.
    Smith BD; Wilson LD
    Oncology (Williston Park); 2003 Sep; 17(9):1281-8. PubMed ID: 14569854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.